Effects of cysteamine on MPTP-induced dopaminergic neurodegeneration in mice

Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine

Marcela V. Karpuj, Mark W. Bêcher, Joe E. Springer et al. · Nature Medicine · 2002 · 379 citations

Medicine, Experimental Neuropathology, Degenerative Disease +7

Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase

María Borrell-Pagés · Journal of Clinical Investigation · 2006 · 230 citations · Full text

Neurodegenerative Diseases, Molecular Neuroscience, Bdnf Levels +15

Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy.

Sjoukje D. Kuipers, Clive R. Bramham · PubMed · 2006 · 210 citations

Neuropsychology, Synaptic Transmission, Adult Synaptic Plasticity +21

Therapeutic effects of coenzyme Q₁₀ (CoQ₁₀) and reduced CoQ₁₀ in the MPTP model of Parkinsonism

Carine Cléren, Lichuan Yang, Beverly Lorenzo et al. · Journal of Neurochemistry · 2007 · 154 citations

Polyhydroxylated fullerene derivative C₆₀(OH)₂₄ prevents mitochondrial dysfunction and oxidative damage in an MPP⁺‐induced cellular model of Parkinson's disease

Xiaoqing Cai, Haiqun Jia, Zhongbo Liu et al. · Journal of Neuroscience Research · 2008 · 148 citations